PapersFlow Research Brief
Genital Health and Disease
Research Guide
What is Genital Health and Disease?
Genital Health and Disease encompasses medical conditions affecting the genital region, with a primary focus on male circumcision's role in reducing HIV infection risk, preventing penile cancer, managing human papillomavirus (HPV) infections, lichen sclerosus, and other sexually transmitted infections, alongside surgical interventions for penile health.
The field includes 66,239 works examining male circumcision's protective effects against HIV, penile cancer, HPV, and related conditions. Research classifies HPV types associated with cervical and genital cancers, identifying high-risk strains like 16, 18, 31, and others. Surgical management and epidemiological studies address penile carcinoma, vulvar disease, and autoimmune conditions in genital health.
Topic Hierarchy
Research Sub-Topics
Male Circumcision for HIV Prevention
This sub-topic examines randomized controlled trials and epidemiological studies on the protective efficacy of male circumcision against heterosexual HIV acquisition. Researchers investigate biological mechanisms, long-term population-level impacts, and implementation strategies in high-prevalence regions.
Circumcision and Penile Cancer Risk
This sub-topic explores cohort studies and meta-analyses linking neonatal and adult circumcision to reduced penile carcinoma incidence. Researchers study histopathological risk factors and oncogenic pathways in uncircumcised populations.
Human Papillomavirus Infection in Males
This sub-topic covers prevalence, persistence, and clearance of HPV genotypes in penile epithelium, including vaccine efficacy trials. Researchers analyze transmission dynamics and oncogenic potential in circumcision contexts.
Lichen Sclerosus of the Genitalia
This sub-topic investigates autoimmune pathogenesis, clinical progression, and circumcision as therapeutic intervention for penile lichen sclerosus. Researchers evaluate histopathological changes and recurrence rates post-surgery.
Surgical Techniques in Penile Circumcision
This sub-topic reviews device-assisted, sleeve resection, and laser circumcision methods, focusing on complications and outcomes. Researchers compare adult voluntary medical male circumcision programs in HIV-endemic areas.
Why It Matters
Male circumcision reduces HIV acquisition risk, as highlighted in the cluster's focus, supporting public health strategies in high-prevalence regions. HPV research demonstrates that 93% of invasive cervical cancers worldwide contain HPV, with Walboomers et al. (1999) in "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide" establishing HPV as a necessary causal factor, informing vaccine development targeting genital HPVs as noted by Bosch et al. (1995) in "Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective," which links over 20 genital HPV types to cervical cancer. Muñoz et al. (2003) in "Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer" classify types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 as carcinogenic, guiding prevention for penile and cervical cancers. Prostate cancer grading updates, such as Epstein et al. (2015) in "The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma," standardize pathology for better treatment outcomes in genital-related malignancies.
Reading Guide
Where to Start
"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide" by Walboomers et al. (1999), as it provides the foundational evidence linking HPV to 93% of cervical cancers, essential for understanding genital HPV disease basics.
Key Papers Explained
Walboomers et al. (1999) in "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide" establishes HPV as necessary for cervical cancer, building the case for genital HPV research. Muñoz et al. (2003) in "Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer" expands this by classifying 15 high-risk types, refining risk assessment. Bosch et al. (1995) in "Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective" quantifies over 20 genital HPV types' prevalence, linking to prevention. de Villiers et al. (2004) in "Classification of papillomaviruses" standardizes taxonomy, supporting these classifications. Epstein et al. (2015) in "The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma" updates prostate pathology, connecting to genital surgical management.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus shifts to precise HPV genotyping in genital cancers, as in de Sanjosé et al. (2010) in "Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study." Consensus updates like Epstein et al. (2015) drive refined grading for penile and prostate conditions amid stable preprint activity.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Human papillomavirus is a necessary cause of invasive cervical... | 1999 | The Journal of Pathology | 8.9K | ✕ |
| 2 | Epidemiologic Classification of Human Papillomavirus Types Ass... | 2003 | New England Journal of... | 6.2K | ✓ |
| 3 | Biochemical Outcome After Radical Prostatectomy, External Beam... | 1998 | JAMA | 4.5K | ✕ |
| 4 | Prevalence of Human Papillomavirus in Cervical Cancer: a World... | 1995 | JNCI Journal of the Na... | 3.4K | ✕ |
| 5 | Classification of papillomaviruses | 2004 | Virology | 3.2K | ✕ |
| 6 | EAU Guidelines on Prostate Cancer | 2007 | European Urology | 3.1K | ✓ |
| 7 | The 2014 International Society of Urological Pathology (ISUP) ... | 2015 | The American Journal o... | 3.1K | ✕ |
| 8 | Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death | 2016 | Trends in Biochemical ... | 3.0K | ✕ |
| 9 | Human papillomavirus and cervical cancer | 2007 | The Lancet | 2.9K | ✕ |
| 10 | Human papillomavirus genotype attribution in invasive cervical... | 2010 | The Lancet Oncology | 2.7K | ✕ |
Frequently Asked Questions
What is the role of HPV in genital cancers?
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, with 93% of cases containing HPV as shown by Walboomers et al. (1999) in "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide." This extends to penile cancer prevention via circumcision. Over 20 genital HPV types are associated with cervical cancer, per Bosch et al. (1995).
Which HPV types are classified as high-risk for cervical cancer?
HPV types 16 and 18, plus 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 are carcinogenic, while 26, 53, and 66 are probably carcinogenic, according to Muñoz et al. (2003) in "Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer." These classifications inform genital health screening and vaccination.
How does male circumcision impact HIV and STI prevention?
Male circumcision reduces HIV infection risk and prevents penile cancer, HPV, lichen sclerosus, and other sexually transmitted infections, as established in the field's core research cluster. Surgical management addresses penile health conditions effectively.
What are key guidelines for prostate cancer management in genital health?
Heidenreich et al. (2007) in "EAU Guidelines on Prostate Cancer" provide European Association of Urology standards for diagnosis and treatment. Gleason grading was updated by Epstein et al. (2015) in "The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma," involving 65 experts from 19 countries.
What is the prevalence of HPV in worldwide cervical cancer?
More than 20 different genital HPV types are associated with cervical cancer, with implications for vaccine development, as detailed by Bosch et al. (1995) in "Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective." This supports genital disease prevention strategies.
How was papillomavirus classification standardized?
de Villiers et al. (2004) in "Classification of papillomaviruses" established a standardized taxonomy for papillomaviruses, aiding research into genital HPV types and related diseases.
Open Research Questions
- ? How do integration events in the HPV L1 gene affect detection accuracy in penile and cervical cancer samples?
- ? Which additional HPV types beyond 16 and 18 warrant classification as high-risk for genital malignancies?
- ? What are the long-term biochemical outcomes of radical prostatectomy versus radiation for localized prostate cancer linked to genital health?
- ? How does male circumcision's efficacy vary against specific STI types like lichen sclerosus in diverse populations?
- ? What refinements are needed in Gleason grading for prostatic carcinoma to improve genital cancer prognosis?
Recent Trends
The field maintains 66,239 works with no specified 5-year growth rate; emphasis persists on HPV classifications from Muñoz et al. and Walboomers et al. (1999), alongside prostate grading consensus by Epstein et al. (2015).
2003No recent preprints or news in the last 12 months indicate steady maturation without new disruptions.
Research Genital Health and Disease with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Genital Health and Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers